InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

139
Insider
Date
Role
Action
Shares
Price
Amount
Jacquelyn L Sumer
24 Feb 2026
Chief Legal Officer
Sell
3,601
$14.47
$52.11K
Jeffrey Alan Jones
24 Feb 2026
Chief Medical Officer
Sell
4,582
$14.47
$66.30K
Nadim Ahmed
24 Feb 2026
President and CEO
Sell
13,515
$14.47
$195.56K
Mary Kay Fenton
20 Feb 2026
Chief Financial Officer
Sell
4,398
$13.62
$59.90K
Nadim Ahmed
20 Feb 2026
President and CEO
Sell
16,381
$13.62
$223.11K
Jacquelyn L Sumer
20 Feb 2026
Chief Legal Officer
Sell
3,742
$13.62
$50.97K
Jeffrey Alan Jones
20 Feb 2026
Chief Medical Officer
Sell
4,982
$13.62
$67.85K
Jennifer Michaelson
12 Feb 2026
Chief Scientific Officer
Sell
416
$12.03
$5.00K
Nadim Ahmed
23 Dec 2025
President and CEO
Sell
9,922
$10.01
$99.32K
Jennifer Michaelson
18 Dec 2025
Chief Scientific Officer
Sell
2,898
$9.67
$28.02K
Jeffrey Alan Jones
18 Dec 2025
Chief Medical Officer
Sell
4,632
$9.67
$44.79K
Jacquelyn L Sumer
18 Dec 2025
Chief Legal Officer
Sell
3,480
$9.67
$33.65K
Jacquelyn L Sumer
25 Feb 2025
Chief Legal Officer
Sell
3,756
$8.53
$32.04K
Jennifer Michaelson
25 Feb 2025
Chief Scientific Officer
Sell
3,756
$8.53
$32.04K
Nadim Ahmed
25 Feb 2025
President and CEO
Sell
12,529
$8.53
$106.87K
Jeffrey Alan Jones
25 Feb 2025
Chief Medical Officer
Sell
4,895
$8.53
$41.75K
Nadim Ahmed
24 Dec 2024
President and CEO
Sell
8,400
$11.87
$99.71K
Jacquelyn L Sumer
18 Dec 2024
Chief Legal Officer
Sell
3,482
$11.41
$39.73K
Jeffrey Alan Jones
18 Dec 2024
Chief Medical Officer
Sell
4,632
$11.41
$52.85K
Jennifer Michaelson
18 Dec 2024
Chief Scientific Officer
Sell
4,693
$11.41
$53.55K
Jennifer Michaelson
12 Dec 2024
Chief Scientific Officer
Sell
3,489
$12.52
$43.68K
Nadim Ahmed
26 Dec 2023
President and CEO
Sell
4,272
$9.24
$39.47K
Jennifer Michaelson
21 Dec 2023
Chief Scientific Officer
Sell
1,145
$8.50
$9.73K
Jeffrey Trigilio
21 Dec 2023
Chief Financial Officer
Sell
1,920
$8.50
$16.32K
Jacquelyn L Sumer
21 Dec 2023
Chief Legal Officer
Sell
1,400
$8.50
$11.90K
Jeffrey Alan Jones
21 Dec 2023
Chief Medical Officer
Sell
1,860
$8.50
$15.81K
Jeffrey Trigilio
18 Dec 2023
Chief Financial Officer
Sell
398
$8.22
$3.27K
Jacquelyn L Sumer
18 Dec 2023
Chief Legal Officer
Sell
290
$8.22
$2.38K
Jennifer Michaelson
18 Dec 2023
Chief Scientific Officer
Sell
238
$8.22
$1.96K
Jeffrey Alan Jones
18 Dec 2023
Chief Medical Officer
Sell
386
$8.22
$3.17K
Jennifer Michaelson
12 Dec 2023
Chief Scientific Officer
Sell
1,068
$7.81
$8.34K
Jeffrey Trigilio
12 Dec 2023
Chief Financial Officer
Sell
1,926
$7.81
$15.04K
Nadim Ahmed
28 Jun 2023
President and CEO
Sell
759
$11.40
$8.65K
Jacquelyn L Sumer
20 Jun 2023
Chief Legal Officer
Sell
291
$12.94
$3.77K
Jeffrey Trigilio
20 Jun 2023
Chief Financial Officer
Sell
399
$12.94
$5.16K
Jennifer Michaelson
20 Jun 2023
Chief Development Officer
Sell
238
$12.94
$3.08K
Jeffrey Alan Jones
20 Jun 2023
Chief Medical Officer
Sell
387
$12.94
$5.01K
Jennifer Michaelson
12 Jun 2023
Chief Development Officer
Sell
176
$13.11
$2.31K
Jeffrey Trigilio
12 Jun 2023
Chief Financial Officer
Sell
319
$13.11
$4.18K
Nadim Ahmed
23 May 2023
President and CEO
Sell
707
$9.15
$6.47K
Jeffrey Trigilio
18 May 2023
Chief Financial Officer
Sell
399
$8.76
$3.50K
Jacquelyn L Sumer
18 May 2023
Chief Legal Officer
Sell
291
$8.76
$2.55K
Jeffrey Alan Jones
18 May 2023
Chief Medical Officer
Sell
394
$8.76
$3.45K
Jennifer Michaelson
18 May 2023
Chief Development Officer
Sell
239
$8.76
$2.09K
Jeffrey Trigilio
12 May 2023
Chief Financial Officer
Sell
347
$8.78
$3.05K
Jennifer Michaelson
12 May 2023
Chief Development Officer
Sell
193
$8.78
$1.69K
Nadim Ahmed
25 Apr 2023
President and CEO
Sell
716
$10.59
$7.58K
Jacquelyn L Sumer
18 Apr 2023
Chief Legal Officer
Sell
290
$10.71
$3.11K
Jennifer Michaelson
18 Apr 2023
Chief Development Officer
Sell
238
$10.71
$2.55K
Jeffrey Trigilio
18 Apr 2023
Chief Financial Officer
Sell
398
$10.71
$4.26K
Jeffrey Alan Jones
18 Apr 2023
Chief Medical Officer
Sell
392
$10.71
$4.20K
Jennifer Michaelson
12 Apr 2023
Chief Development Officer
Sell
176
$10.22
$1.80K
Jeffrey Trigilio
12 Apr 2023
Chief Financial Officer
Sell
318
$10.22
$3.25K
Nadim Ahmed
23 Mar 2023
President and CEO
Sell
706
$10.51
$7.42K
Jacquelyn L Sumer
20 Mar 2023
Chief Legal Officer
Sell
305
$11.32
$3.45K
Jennifer Michaelson
20 Mar 2023
Chief Development Officer
Sell
238
$11.32
$2.69K
Jeffrey Alan Jones
20 Mar 2023
Chief Medical Officer
Sell
390
$11.32
$4.41K
Jeffrey Trigilio
20 Mar 2023
Chief Financial Officer
Sell
399
$11.32
$4.52K
Vision SCS F2
4 Aug 2022
10% owner
Sell
25,989
$14.31
$371.79K
Vision SCS F2
3 Aug 2022
10% owner
Sell
19,129
$14.24
$272.33K
Vision SCS F2
2 Aug 2022
10% owner
Sell
4,792
$14.10
$67.55K
Corrine Savill
19 Jul 2022
Acting Chief Business Officer
Sell
14,958
$15.22
$227.66K
Corrine Savill
18 Jul 2022
Acting Chief Business Officer
Sell
5,042
$15.06
$75.93K
Corrine Savill
11 Jul 2022
Acting Chief Business Officer
Sell
200
$13.85
$2.77K
Corrine Savill
11 Jul 2022
Acting Chief Business Officer
Sell
39,800
$13.33
$530.53K
F2 Bioscience I 2017 Ltd
23 Jun 2022
10% owner
Sell
29,631
$13.00
$385.31K
F2 Bioscience I 2017 Ltd
22 Jun 2022
10% owner
Sell
49,953
$12.70
$634.58K
F2 Bioscience I 2017 Ltd
21 Jun 2022
10% owner
Sell
22,319
$12.77
$284.93K
Vision SCS F2
16 May 2022
10% owner
Sell
35,158
$11.23
$394.83K
Vision SCS F2
13 May 2022
10% owner
Sell
34,189
$10.48
$358.33K
Vision SCS F2
13 May 2022
10% owner
Sell
85,319
$9.96
$850.04K
Vision SCS F2
12 May 2022
10% owner
Sell
264,072
$9.25
$2.44M
Leigh Zawel
15 Oct 2021
See Remarks
Sell
19,574
$25.00
$489.35K
Leigh Zawel
7 Oct 2021
See Remarks
Sell
1,079
$25.00
$26.98K
Leigh Zawel
20 Sep 2021
See Remarks
Sell
7,468
$25.16
$187.89K
Ansbert Gadicke
16 Sep 2021
Director
Sell indirect
3,124
$29.06
$90.78K
Ansbert Gadicke
16 Sep 2021
Director
Sell
432
$29.06
$12.55K
UBS Oncology Impact Fund L.P.
16 Sep 2021
10% owner
Sell
3,124
$29.06
$90.78K
Ansbert Gadicke
15 Sep 2021
Director
Sell indirect
6,425
$29.16
$187.35K
Ansbert Gadicke
15 Sep 2021
Director
Sell
888
$29.16
$25.89K
UBS Oncology Impact Fund L.P.
15 Sep 2021
10% owner
Sell
6,425
$29.16
$187.35K
Ansbert Gadicke
14 Sep 2021
Director
Sell indirect
7,106
$29.17
$207.28K
Ansbert Gadicke
14 Sep 2021
Director
Sell
982
$29.17
$28.64K
UBS Oncology Impact Fund L.P.
14 Sep 2021
10% owner
Sell
7,106
$29.17
$207.28K
Ansbert Gadicke
13 Sep 2021
Director
Sell indirect
3,595
$29.10
$104.61K
Ansbert Gadicke
13 Sep 2021
Director
Sell
497
$29.10
$14.46K
UBS Oncology Impact Fund L.P.
13 Sep 2021
10% owner
Sell
3,595
$29.10
$104.61K
Ansbert Gadicke
10 Sep 2021
Director
Sell indirect
5,931
$29.04
$172.24K
Ansbert Gadicke
10 Sep 2021
Director
Sell
820
$29.04
$23.81K
UBS Oncology Impact Fund L.P.
10 Sep 2021
10% owner
Sell
5,931
$29.04
$172.24K
Ansbert Gadicke
9 Sep 2021
Director
Sell indirect
13,727
$29.35
$402.89K
Ansbert Gadicke
9 Sep 2021
Director
Sell
1,898
$29.35
$55.71K
UBS Oncology Impact Fund L.P.
9 Sep 2021
10% owner
Sell
13,727
$29.35
$402.89K
Ansbert Gadicke
8 Sep 2021
Director
Sell indirect
10,842
$29.11
$315.61K
Ansbert Gadicke
8 Sep 2021
Director
Sell
1,499
$29.11
$43.64K
UBS Oncology Impact Fund L.P.
8 Sep 2021
10% owner
Sell
10,842
$29.11
$315.61K
Leigh Zawel
7 Sep 2021
See Remarks
Sell
28,118
$28.95
$814.02K
Ansbert Gadicke
7 Sep 2021
Director
Sell indirect
25,067
$29.04
$727.95K
Ansbert Gadicke
7 Sep 2021
Director
Sell
3,465
$29.04
$100.62K
UBS Oncology Impact Fund L.P.
7 Sep 2021
10% owner
Sell
25,067
$29.04
$727.95K
Ansbert Gadicke
3 Sep 2021
Director
Sell indirect
12,731
$29.60
$376.84K
Ansbert Gadicke
3 Sep 2021
Director
Sell
1,760
$29.60
$52.10K
UBS Oncology Impact Fund L.P.
3 Sep 2021
10% owner
Sell
12,731
$29.60
$376.84K
Ansbert Gadicke
2 Sep 2021
Director
Sell indirect
15,757
$29.46
$464.20K
Ansbert Gadicke
2 Sep 2021
Director
Sell
2,178
$29.46
$64.16K
UBS Oncology Impact Fund L.P.
2 Sep 2021
10% owner
Sell
15,757
$29.46
$464.20K
Ansbert Gadicke
1 Sep 2021
Director
Sell indirect
5,714
$29.47
$168.39K
Ansbert Gadicke
1 Sep 2021
Director
Sell
790
$29.47
$23.28K
UBS Oncology Impact Fund L.P.
1 Sep 2021
10% owner
Sell
5,714
$29.47
$168.39K
Ansbert Gadicke
31 Aug 2021
Director
Sell indirect
1,553
$30.14
$46.81K
Ansbert Gadicke
31 Aug 2021
Director
Sell
215
$30.14
$6.48K
Ansbert Gadicke
31 Aug 2021
Director
Sell indirect
1,285
$29.43
$37.82K
Ansbert Gadicke
31 Aug 2021
Director
Sell
177
$29.43
$5.21K
UBS Oncology Impact Fund L.P.
31 Aug 2021
10% owner
Sell
1,553
$30.14
$46.81K
UBS Oncology Impact Fund L.P.
31 Aug 2021
10% owner
Sell
1,285
$29.43
$37.82K
UBS Oncology Impact Fund L.P.
30 Aug 2021
10% owner
Sell
31,001
$29.30
$908.33K
Ansbert Gadicke
30 Aug 2021
Director
Sell indirect
31,001
$29.30
$908.33K
Ansbert Gadicke
30 Aug 2021
Director
Sell
4,285
$29.30
$125.55K
UBS Oncology Impact Fund L.P.
27 Aug 2021
10% owner
Sell
13,357
$29.09
$388.56K
Ansbert Gadicke
27 Aug 2021
Director
Sell indirect
13,357
$29.09
$388.56K
Ansbert Gadicke
27 Aug 2021
Director
Sell
1,846
$29.09
$53.70K
Ansbert Gadicke
25 Aug 2021
Director
Sell indirect
1,713
$29.09
$49.83K
Ansbert Gadicke
25 Aug 2021
Director
Sell
237
$29.09
$6.89K
UBS Oncology Impact Fund L.P.
25 Aug 2021
10% owner
Sell
1,713
$29.09
$49.83K
Ansbert Gadicke
24 Aug 2021
Director
Sell indirect
50,882
$29.48
$1.50M
Ansbert Gadicke
24 Aug 2021
Director
Sell
7,025
$29.48
$207.10K
UBS Oncology Impact Fund L.P.
24 Aug 2021
10% owner
Sell
50,822
$29.48
$1.50M
Leigh Zawel
23 Aug 2021
See Remarks
Sell
28,118
$29.00
$815.42K
Ansbert Gadicke
23 Aug 2021
Director
Sell indirect
53,359
$29.11
$1.55M
Ansbert Gadicke
23 Aug 2021
Director
Sell
7,376
$29.11
$214.72K
UBS Oncology Impact Fund L.P.
23 Aug 2021
10% owner
Sell
53,359
$29.11
$1.55M
Ansbert Gadicke
11 Aug 2021
Director
Sell indirect
2,510
$29.05
$72.92K
Ansbert Gadicke
11 Aug 2021
Director
Sell
347
$29.05
$10.08K
UBS Oncology Impact Fund L.P.
11 Aug 2021
10% owner
Sell
2,510
$29.05
$72.92K
Leigh Zawel
10 Aug 2021
See Remarks
Sell
1,817
$28.49
$51.77K
Leigh Zawel
10 Aug 2021
See Remarks
Sell
3,191
$27.34
$87.24K
Leigh Zawel
10 Aug 2021
See Remarks
Sell
1,906
$26.50
$50.51K
Leigh Zawel
9 Aug 2021
See Remarks
Sell
1,700
$27.11
$46.09K
Leigh Zawel
9 Aug 2021
See Remarks
Sell
19,504
$26.52
$517.25K
Show all 213 transactions →

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 34
Sales at will 139
Transactions with no price 0
Shares from compensation/vesting 31,067,955
Sales filed before the plan box existed 81
History held since 11 Jan 2021